For the past couple of years, CBD has been making waves due to its numerous benefits. The compound is extracted from the cannabis plant, and while it won’t make you high, users have reported a variety of medical benefits. Opinion on CBD is divided, though. There’s plenty of anecdotal evidence of its efficacy, but limited regulation and a somewhat bad reputation have been a thorn in the industry’s side.
Despite the murky atmosphere, a few people have been actively working to spread awareness on the benefits of CBD. Green Light, a compelling documentary by Melbourne documentary filmmaker Ned Donahue prosecutes the case for the health benefits of CBD. The documentary claims that oral and topical treatments can significantly benefit patients with cancer, chronic pain and other debilitating illnesses.
Donahue, 27, first came into contact with CBD when he executive produced director Andy McCallum’s short documentary, The Pot Doctor. It featured rogue Doctor Andrew Katelaris who was deregistered in 2005 for producing cannabis to treat sick kids with epilepsy. The idea for Green Light was born after Donahue saw how effective the CBD had been.
It was shot over two days, and it featured two proponents of CBD, Nicholas Morley, the founder of Buddhist Punk, and a man who only identifies as CBD Luke. Both of them reside in NSW’s Northern Rivers Region, and they both struggled with and overcame mental ill-health and addiction. Now, they try to help as many people as they can, even if it conflicts with the law, often without charge.
Famous singer and actress Olivia Newton-John has also come out as a staunch supporter of the non-psychoactive cannabinoid. She’s been using CBD since she was diagnosed with metastatic breast cancer, and it has helped her get off opioids and painkillers. She claims that Australia could and should become the epicenter for cannabis research. During the Olivia Newton-John Wellness Research Run held in Melbourne on October 6th, she told the Sunday Herald Sun that “cannabis should be made available to everyone who needs it.”
October 6th was a big day for CBD users as federal health minister Greg Hunt announced $3 million had been provided to fund medical cannabis research.
Donahue states that there has been very limited progress in legalizing medical cannabis in Victoria. Users have to go through numerous obstacles, the products are often overpriced and you can never be sure about the quality. He hopes that until proper regulations for CBD have been drawn up, the government will allow these guys to continue with the good work they’ve been doing.
While this documentary was shot in Australia, analysts are strongly convinced that CBD industry players like SinglePoint Inc. (OTCQB: SING) and Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) believe the conclusion about CBD becoming commonplace like vitamin pills is valid for the U.S. and the rest of the world.
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Do you have a questions or are you interested in working with CNW? Ask Our Editor